Ethiopia introduced human papillomavirus (HPV) vaccination in December 2018 to reduce the risk of HPV-associated cancers. Initially administered as a two-dose schedule to 14-year-old girls, the country adopted a single-dose strategy in 2023. Coverage estimates¹ for 2023 ranged from 56 to 86 percent, highlighting gaps in reaching eligible girls, particularly those out of school or in hard-to-reach areas. Learn more about the key takeaways from multistakeholder consultation workshops.